ask="7.20"
ask_size="700"
average_daily_volume="67387"
bid="5.18"
bid_size="900"
book_value="5.08"
change="+0.40"
change_from_200_day_moving_average="0.34"
change_from_50_day_moving_average="1.26"
change_from_52_week_high="-6.75"
change_From_52_week_low="2.34"
change_in_percent="+7.14%"
close="6.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-3.75"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="6.18"
high_52_weeks="12.75"
last_trade_date="2/22/2017"
last_trade_price="6.00"
last_trade_size="935"
last_trade_time="4:00pm"
low="5.36"
low_52_weeks="3.66"
market_capitalization="80.58M"
moving_average_200_day="5.66"
moving_average_50_day="4.74"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="5.65"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+6.03%"
percent_change_from_50_day_moving_average="+26.45%"
percent_change_from_52_week_high="-52.94%"
percent_change_from_52_week_low="+63.93%"
previous_close="5.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.10"
price_per_sales="15.14"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="2.04"
stock_exchange="NGM"
symbol="AGLE"
volume="206023"
weeks_range_52="3.66 - 12.75"
